Development of a SETD2-related Immune Prognostic Signature in Clear Cell Renal Cell Carcinoma
Medicine（2022）
Key words
clear cell renal cell carcinoma,immune prognostic signature,individualized medicine,SETD2 mutation
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined